FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Scholl Hendrik Peter
(Last) (First) (Middle)
GOTTHARDSTRASSE 26
(Street)
ZUG 6300
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026 		3. Issuer Name and Ticker or Trading Symbol
BELITE BIO, INC [ BLTE ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Medical Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Share 35,000
I
By Bioptima Ltd.
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)   (1) 08/31/2034 Ordinary Shares 100,000 48.68 I By Bioptima Ltd.
Stock Option (right to buy)   (2) 02/11/2035 Ordinary Shares 75,000 54.88 I By Bioptima Ltd.
Stock Option (right to buy)   (3) 01/08/2036 Ordinary Shares 40,000 158.36 I By Bioptima Ltd.
Explanation of Responses:
1. The option shall vest (i) as to 50,000 ordinary shares on the first anniversary of September 1, 2024, and (ii) as to 50,000 ordinary shares in 24 equal and continuous monthly installments for each full month following the first anniversary of September 1, 2024, subject to continued service to the Issuer on each such date.
2. The option shall vest (i) as to 12,500 ordinary shares on September 1, 2025, and (ii) as to 62,500 ordinary shares in 30 equal and continuous monthly installments for each full month following September 1, 2025, subject to continued service to the Issuer on each such date.
3. The option shall vest (i) as to 13,333 ordinary shares on January 9, 2027, (ii) as to 13,333 ordinary shares on January 9, 2028, and (iii) as to 13,334 ordinary shares on January 9, 2029.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Hendrik Peter Scholl 03/18/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-24